SWX (SWX)

$6.3B
Market Cap
26.9
P/E Ratio
0.60
Beta
2.86%
Dividend Yield
Piotroski 6/9Altman Z 1.1 DistressBeneish M 17.20 Flag (> −2.22)ROIC−WACC -2.5%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 1.1. Beneish M-Score of 17.20 exceeds the -2.22 academic threshold — earnings quality may warrant further review.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency of this entity presents a notable divergence, characterized by an ROIC-WACC spread that fails to signal robust value creation despite a Piotroski F-Score of 6/9 indicating moderate financial strength. The DuPont decomposition reveals that the 11.1% return on equity is driven almost exclusively by high leverage (2.63x) and expansive net margins (22.7%), rather than operational asset turnover, which remains sluggish at just 0.19x. This structural reliance on debt to amplify returns is further complicated by a Beneish M-Score of 17.20, a metric that typically flags potential earnings manipulation risks when significantly elevated above standard thresholds, suggesting the high margins may not be sustainable or transparently reported.

Valuation metrics currently reflect an optimistic outlook inconsistent with recent operational performance; the stock trades at a forward P/E multiple of 26.9x, which implies significant future growth expectations given that revenue has contracted by 21.6% year-over-year. While the high gross margin of 46.3% suggests strong pricing power or cost advantages on paper, the market's willingness to assign such a premium multiple despite shrinking top-line results indicates priced-in recovery assumptions that have not yet materialized in earnings growth. The disconnect between the current valuation and the negative revenue trajectory creates a scenario where any further deterioration in fundamentals could lead to a sharp re-rating of equity value downward.

Insider activity reinforces concerns regarding internal confidence, with net selling totaling $245,510 over the last 90 days, suggesting management or major shareholders may be reducing exposure ahead of potential earnings misses. The combination of declining revenue, a leverage-dependent return profile, and insider outflows paints a picture of elevated downside risk where the current multiple offers little margin for error if operational headwinds persist. Investors must weigh whether the high margins are genuine competitive moats or temporary anomalies before committing capital at these levels.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
1.1
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
17.20
Beneish M-Score
Above threshold — earnings quality may warrant further review per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

46.3%
Gross Margin
22.7%
Net Margin
4.4%
ROIC
7.0%
WACC
ROIC − WACC Spread: -2.5%— Negative spread.
-21.6%
Revenue Growth (YoY)
+121.2%
Earnings Growth (YoY)
-251.8M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

22.7%
Net Profit Margin
NI ÷ Revenue
×
0.19x
Asset Turnover
Revenue ÷ Assets
×
2.63x
Equity Multiplier
Assets ÷ Equity
=
11.1%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

1.63x
Debt / Equity
1.28x
Current Ratio
2.6x
Interest Coverage
3.3x
Net Debt / EBITDA
-2.74%
FCF Yield
864.7M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-245,510
Net Selling
0
Buy Transactions
1
Sale Transactions
2026-02-20BROWN JUSTIN LEESold 2/8 qtrsGrant31,349 shares
2026-02-19HALLER KAREN SGrant50,060 shares
2026-02-19THORNTON LESLIE TGrant1,725 shares
2026-02-19LEWIS-RAYMOND JANE RGrant1,725 shares
2026-02-19LINGINFELTER HENRY PGrant1,725 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.49
Act: $1.65
+10.4%
Q3
✓ Beat
Est: $0.47
Act: $0.53
+11.9%
Q2
✓ Beat
Est: $0.04
Act: $0.06
+50.8%
Q1
✗ Miss
Est: $1.38
Act: $1.36
-1.1%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

17.4
Forward P/E
PEG Ratio
1.59
Price/Book
653664
Avg Volume
$90.00
52W High
$64.69
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$566M
Tracked Passive Exposure
8
ETFs Holding SWX
0.11%
Avg Weight in ETFs
$508B
Total ETF AUM

When investors buy or sell ETFs like DVY or VPU, the fund manager is mechanically forced to buy or sell SWX shares regardless of SWX's individual fundamentals. We estimate $566M of passive capital is structurally linked to SWX through 8 tracked ETFs. Passive flows have a limited but growing influence on SWX's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in SWX to visualize passive redemption contagion across ETFs and collateral stocks.

SWX Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
SWXEpicenterVBETFVYMETFVXFETFNEEHigh RiskSOHigh RiskDUKHigh RiskCEGMed RiskAEPHigh Risk
SWX Price Drop (%)0

If SWX (SWX) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NextEra Energy Inc. (NEE) as the most exposed collateral stock, sharing 1 ETFs with SWX. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 11 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

SWX Ownership Dynamics

Ticker
SWX

Float lock-up computed from 11 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

SWX Capital Efficiency

How efficiently does SWX convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$-251,790,000
EBITDA
$865M
FCF Conversion
-29%
Reinvestment Rate
129%
-29% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
4.4%
ROIC − WACC Spread
-2.5%

SWX converts -29% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 129% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-2.5%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-131,832$89.87$164,641.84
2026-05-0632$93.67$2,997.44
2026-04-17432$91.36$39,467.52
2026-04-15254$91.38$23,210.52
2026-03-311$87.31$87.31
2026-03-26119$85.82$10,212.58
2026-03-23132$83.58$11,032.56
2026-03-18533$87.37$46,568.21
2026-02-2051$87.24$4,449.24
2026-02-1912$86.64$1,039.68
2026-02-1339$87.11$3,397.29
2026-01-132$81.60$163.2
2026-01-081,519$80.46$122,218.74
2025-12-1249$80.00$3,920
2025-12-08159$79.08$12,573.72
2025-11-1096$79.84$7,664.64
2025-10-1623$78.35$1,802.05
2025-10-14112$77.23$8,649.76
2025-10-0810$78.72$787.2
2025-10-0710$78.18$781.8

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare SWX to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.